InspireMD
NSPR • NASDAQ
InspireMD is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Marvin L. Slosman, with a market cap of $67.4M.
CEOMarvin L. Slosman
Next Earnings
Upcoming earnings announcement for InspireMD
Date
Friday, May 8, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.18
Revenue Estimate
$2.7M
Earnings History
Past 12 earnings reports for InspireMD
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 18, 2026 | Q4 2025 | -$0.14Est: -$0.20 | +30.0% | $3.1MEst: $2.7M | +17.9% | — |
| Nov 4, 2025 | Q3 2025 | -$0.17Est: -$0.18 | +5.6% | $2.5MEst: $1.8M | +38.3% |  10-Q |
| Aug 5, 2025 | Q2 2025 | -$0.26Est: -$0.25 | -4.0% | $1.8MEst: $1.5M | +16.5% | 10-Q |
| May 9, 2025 | Q1 2025 | -$0.22Est: -$0.20 | -10.0% | $1.5MEst: $1.5M | +5.4% | 10-Q |
| Mar 12, 2025 | Q4 2024 | -$0.18Est: -$0.19 | +5.3% | $1.9MEst: $1.8M | +7.1% | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.16Est: $0.00 | — | $1.8MEst: $1.7M | +4.0% | 10-Q |
| Aug 6, 2024 | Q2 2024 | -$0.22Est: -$0.20 | -10.0% | $1.7MEst: $1.7M | -0.1% | 10-Q |
| May 14, 2024 | Q1 2024 | -$0.21Est: -$0.15 | -40.0% | $1.5MEst: $1.4M | +9.5% | 10-Q |
| Mar 6, 2024 | Q4 2023 | -$0.16Est: -$0.20 | +20.0% | $1.8MEst: $1.6M | +8.0% | 10-K |
| Nov 6, 2023 | Q3 2023 | -$0.15Est: -$0.15 | 0.0% | $1.6MEst: $1.5M | +3.7% | — |
| Aug 7, 2023 | Q2 2023 | -$0.24Est: -$0.30 | +20.0% | $1.6MEst: $1.6M | +6.4% | 10-Q |
| May 15, 2023 | Q1 2023 | -$0.53Est: -$0.68 | +22.1% | $1.2MEst: $1.0M | +23.9% | 10-Q |